相关实验视频
Updated: Jun 1, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
89
机器学习模型用于痴呆症查,以使用血液标记物和人口特征的正电子发射断层扫描对脑粉样蛋白阳性进行分类:一项追溯观察性研究
Noriyuki Kimura1, Kotaro Sasaki2, Teruaki Masuda3
1Department of Neurology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan. noriyuki@oita-u.ac.jp.
Alzheimer's research & therapy
|January 21, 2025
概括
机器学习模型使用常规数据有效识别了阿尔茨海默病中的粉样β阳性. 这种方法有助于在临床前和临床前阶段的早期检测,以便及时干预.
科学领域:
- 神经学 神经学
- 医疗信息学 医疗信息学
- 生物统计学 生物统计学
背景情况:
- 脑内粉样β (Aβ) 积累是阿尔茨海默病 (AD) 病理学的关键早期事件.
- 早期识别粉样蛋白病理对于及时治疗患者至关重要.
- 这项研究的重点是为初级保健开发可访问的查工具.
研究的目的:
- 开发和评估机器学习模型来分类粉样蛋白正子辐射断层扫描 (PET) Aβ-阳性.
- 评估人口统计学,常规血液和认知测试数据对这一分类的有用性.
- 为了确定早期发现阿尔茨海默病的潜在生物标志物.
主要方法:
- 一项回顾性观察性研究分析了来自262名轻度认知障碍或正常认知的参与者的数据.
- 使用了五个机器学习模型 (变量组合) 与三个分类算法 (L2规范后勤回归,内核SVM,弹性网).
- 评估了34个预先选择的变量,包括人口统计,血液测试和认知分数.
主要成果:
- 机器学习模型证明了Aβ-阳性的有效分类.
- 性能最好的模型 (人口统计,血液检测,认知得分,ApoE4表型) 实现了0.76 (0.01) 的平均ROC AUC.
- 在使用血液测试结果的模型中,甲状腺刺激激素和平均体积是显著的贡献者.
结论:
- 使用常规可用的数据的机器学习模型可以有效地分类Aβ阳性.
- 这种方法对识别患有临床前和前期阿尔茨海默氏症的个体有希望.
- 这些发现支持使用可访问的数据用于早期阿尔茨海默氏症病理学查.
关键词:
AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD ADD was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.粉样蛋白 β 阳性痴呆症是一种痴呆症.机器学习是机器学习.相关概念视频
Dementia
93
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
93
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160

